$JKSM
Jacksam Corp

2022 Q3 Form 10-Q Financial Statement

#000147793222008582 Filed on November 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3
Revenue $492.9K
YoY Change -74.72%
Cost Of Revenue $431.5K
YoY Change -68.14%
Gross Profit $61.44K
YoY Change -89.68%
Gross Profit Margin 12.46%
Selling, General & Admin $174.8K
YoY Change -32.14%
% of Gross Profit 284.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $140.00
YoY Change -72.0%
% of Gross Profit 0.23%
Operating Expenses $397.6K
YoY Change -31.65%
Operating Profit -$336.1K
YoY Change -2560.66%
Interest Expense $53.03K
YoY Change -76.1%
% of Operating Profit
Other Income/Expense, Net $17.70K
YoY Change -114.05%
Pretax Income -$318.4K
YoY Change 183.49%
Income Tax
% Of Pretax Income
Net Earnings -$318.4K
YoY Change 183.49%
Net Earnings / Revenue -64.6%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 81.09M shares
Diluted Shares Outstanding 80.86M shares

Balance Sheet

Concept 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $298.8K
YoY Change -51.19%
Cash & Equivalents $298.8K
Short-Term Investments
Other Short-Term Assets $94.38K
YoY Change 581.44%
Inventory $208.5K
Prepaid Expenses $94.38K
Receivables $874.3K
Other Receivables $0.00
Total Short-Term Assets $1.476M
YoY Change -0.84%
LONG-TERM ASSETS
Property, Plant & Equipment $613.00
YoY Change -66.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $86.21K
YoY Change 4595.53%
TOTAL ASSETS
Total Short-Term Assets $1.476M
Total Long-Term Assets $86.21K
Total Assets $1.562M
YoY Change 4.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $763.6K
YoY Change 67.17%
Accrued Expenses $2.500M
YoY Change 28.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $556.8K
YoY Change -14.87%
Total Short-Term Liabilities $4.559M
YoY Change -5.18%
LONG-TERM LIABILITIES
Long-Term Debt $620.0K
YoY Change -26.94%
Other Long-Term Liabilities $55.12K
YoY Change
Total Long-Term Liabilities $675.2K
YoY Change -20.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.559M
Total Long-Term Liabilities $675.2K
Total Liabilities $5.234M
YoY Change -7.47%
SHAREHOLDERS EQUITY
Retained Earnings -$11.45M
YoY Change 4.69%
Common Stock $81.09K
YoY Change 10.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.941M
YoY Change
Total Liabilities & Shareholders Equity $1.562M
YoY Change 4.82%

Cashflow Statement

Concept 2022 Q3
OPERATING ACTIVITIES
Net Income -$318.4K
YoY Change 183.49%
Depreciation, Depletion And Amortization $140.00
YoY Change -72.0%
Cash From Operating Activities -$82.83K
YoY Change -82.54%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.950K
YoY Change -97.58%
NET CHANGE
Cash From Operating Activities -82.83K
Cash From Investing Activities
Cash From Financing Activities 7.950K
Net Change In Cash -74.88K
YoY Change -48.78%
FREE CASH FLOW
Cash From Operating Activities -$82.83K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Gross Profit
GrossProfit
1613117 usd
CY2022Q3 us-gaap Salaries And Wages
SalariesAndWages
222731 usd
CY2021Q3 us-gaap Salaries And Wages
SalariesAndWages
324009 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
us-gaap Lease Cost
LeaseCost
82668 usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity File Number
EntityFileNumber
033-33263
dei Entity Registrant Name
EntityRegistrantName
Jacksam Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3566284
dei Entity Address Address Line1
EntityAddressAddressLine1
3100 Airway Avenue Suite 138
dei Entity Address City Or Town
EntityAddressCityOrTown
Costa Mesa
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92626
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
605-3580
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
81088719 shares
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
JKSM
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74490147 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81088719 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
14279965 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
11189056 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2469136 shares
CY2022Q3 us-gaap Deferred Revenue
DeferredRevenue
147772 usd
us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
18066667 shares
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000860543
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
171771 usd
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
32785 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2022Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2220175 usd
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2264390 usd
CY2022Q3 jksm Notes And Loans Payable Non Current
NotesAndLoansPayableNonCurrent
620028 usd
CY2021Q4 jksm Notes And Loans Payable Non Current
NotesAndLoansPayableNonCurrent
705038 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
259422 usd
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81088719 shares
CY2021Q4 jksm Shares Payable
SharesPayable
2222223 shares
CY2022Q3 us-gaap Revenues
Revenues
492891 usd
CY2021Q3 us-gaap Revenues
Revenues
1949392 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
179828 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2832271 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3767498 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
61437 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
595308 usd
us-gaap Gross Profit
GrossProfit
905004 usd
us-gaap Salaries And Wages
SalariesAndWages
764211 usd
us-gaap Salaries And Wages
SalariesAndWages
989460 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
174832 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
257639 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
550312 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
976528 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
397563 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
581648 usd
us-gaap Operating Expenses
OperatingExpenses
1314523 usd
us-gaap Operating Expenses
OperatingExpenses
1965988 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-336126 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
13660 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-409519 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-352871 usd
CY2022Q3 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
70733 usd
CY2021Q3 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
95882 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
435730 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
1171242 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
53030 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
221865 usd
us-gaap Interest Expense
InterestExpense
350153 usd
us-gaap Interest Expense
InterestExpense
735750 usd
CY2022Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 usd
CY2021Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
58642 usd
CY2022Q3 jksm Gain On Settlement Of Notes Payable
GainOnSettlementOfNotesPayable
0 usd
CY2021Q3 jksm Gain On Settlement Of Notes Payable
GainOnSettlementOfNotesPayable
0 usd
jksm Gain On Settlement Of Notes Payable
GainOnSettlementOfNotesPayable
0 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
jksm Gain On Settlement Of Notes Payable
GainOnSettlementOfNotesPayable
160164 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17703 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-125983 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
85577 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
537014 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-318423 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-112323 usd
us-gaap Net Income Loss
NetIncomeLoss
-323942 usd
us-gaap Net Income Loss
NetIncomeLoss
184143 usd
CY2022Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
23340 usd
CY2021Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3107 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
69260 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
4315 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-341763 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-115430 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-393202 usd
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
80855219 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
73645455 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
78700014 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
71490810 shares
CY2022Q3 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
80855219 shares
CY2021Q3 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
73645455 shares
us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
78700014 shares
us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
76522446 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4514303 usd
CY2022Q1 jksm Issuance Of Series B Preferred Stock Net Of Fees Amount
IssuanceOfSeriesBPreferredStockNetOfFeesAmount
890000 usd
CY2022Q1 jksm Common Stock And Warrants Issued In Connection With Preferred Stock Amount
CommonStockAndWarrantsIssuedInConnectionWithPreferredStockAmount
0 usd
CY2022Q1 jksm Dividends On Series A Preferred Stock Amount
DividendsOnSeriesAPreferredStockAmount
-22833 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
29384 usd
CY2022Q2 jksm Common Stock Issued For Share Payable Amount
CommonStockIssuedForSharePayableAmount
0 usd
CY2022Q2 jksm Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
68977 usd
CY2022Q2 jksm Common Stock And Warrants Issued In Connection With Preferred Stock Amount
CommonStockAndWarrantsIssuedInConnectionWithPreferredStockAmount
0 usd
CY2022Q2 jksm Dividends On Series A Preferred Stock Amount
DividendsOnSeriesAPreferredStockAmount
-23087 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-34903 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-3606765 usd
CY2022Q3 jksm Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
8000 usd
CY2022Q3 jksm Dividends On Series A Preferred Stock Amount
DividendsOnSeriesAPreferredStockAmount
-23340 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-318423 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-5705452 usd
CY2021Q1 jksm Common Stock Issued For Debt Conversion Amount
CommonStockIssuedForDebtConversionAmount
614198 usd
CY2021Q1 jksm Common Stock Issued For Deferred Finance Cost Amount
CommonStockIssuedForDeferredFinanceCostAmount
72000 usd
CY2021Q1 jksm Sale Of Common Stock Units Amount
SaleOfCommonStockUnitsAmount
187800 usd
CY2021Q1 jksm Common Stock And Warrants Issued For Settlement Of Notes Payable Amount
CommonStockAndWarrantsIssuedForSettlementOfNotesPayableAmount
141118 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8682 usd
us-gaap Interest Expense Other
InterestExpenseOther
141020 usd
us-gaap Interest Expense Other
InterestExpenseOther
0 usd
CY2021Q2 jksm Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
6211 usd
CY2021Q2 jksm Sale Of Common Stock Units Amount
SaleOfCommonStockUnitsAmount
0 usd
CY2021Q2 jksm Exercise Of Warrants Amount
ExerciseOfWarrantsAmount
0 usd
CY2021Q2 jksm Extinguishment Of Derivative Liability Due To Conversion
ExtinguishmentOfDerivativeLiabilityDueToConversion
72958 usd
CY2021Q2 jksm Shares Returned Under Share Lending Agreement Amount
SharesReturnedUnderShareLendingAgreementAmount
0 usd
CY2021Q2 jksm Issuance Of Series A Preferred Stock Amount
IssuanceOfSeriesAPreferredStockAmount
0 usd
CY2021Q2 jksm Dividends On Series A Preferred Stock Amount
DividendsOnSeriesAPreferredStockAmount
-1208 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
305147 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-4315910 usd
CY2021Q3 jksm Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
9017 usd
CY2021Q3 jksm Dividends On Series A Preferred Stock Amount
DividendsOnSeriesAPreferredStockAmount
-3107 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-112323 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-4422323 usd
us-gaap Net Income Loss
NetIncomeLoss
-323942 usd
us-gaap Net Income Loss
NetIncomeLoss
184143 usd
us-gaap Depreciation
Depreciation
859 usd
us-gaap Depreciation
Depreciation
1512 usd
us-gaap Share Based Compensation
ShareBasedCompensation
76977 usd
us-gaap Share Based Compensation
ShareBasedCompensation
15228 usd
jksm Gain On Settlement Of Notes Payable
GainOnSettlementOfNotesPayable
0 usd
jksm Gain On Settlement Of Notes Payable
GainOnSettlementOfNotesPayable
160164 usd
jksm Loss On Conversion Of Notes Payable
LossOnConversionOfNotesPayable
0 usd
jksm Loss On Conversion Of Notes Payable
LossOnConversionOfNotesPayable
58642 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
63625 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
599052 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
20225 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 usd
jksm Derivative Gain Loss
DerivativeGainLoss
-435730 usd
jksm Derivative Gain Loss
DerivativeGainLoss
-1171242 usd
us-gaap Impairment Of Investments
ImpairmentOfInvestments
18800 usd
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-283138 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-337912 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-30545 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-42326 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-85779 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
134609 usd
jksm Increase Decrease Of Right Of Use Liabilities
IncreaseDecreaseOfRightOfUseLiabilities
-17916 usd
jksm Increase Decrease Of Right Of Use Liabilities
IncreaseDecreaseOfRightOfUseLiabilities
0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
324327 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
34614 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-23999 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-325486 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-555216 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1009330 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
570000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
300000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
905503 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
5000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
231194 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1024024 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
312009 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
53605 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
250000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
890000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
252000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
509185 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1131916 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
46031 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
122586 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
344811 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
489560 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
298780 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
612146 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Interest Paid
InterestPaid
13709 usd
us-gaap Interest Paid
InterestPaid
118732 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
105822 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
jksm Common Stock Issued To Settle Convertible Notes Payable
CommonStockIssuedToSettleConvertibleNotesPayable
0 usd
jksm Common Stock Issued To Settle Convertible Notes Payable
CommonStockIssuedToSettleConvertibleNotesPayable
614198 usd
jksm Derivative Liability Recognized At Issuance Of Warrants And Conversion Option
DerivativeLiabilityRecognizedAtIssuanceOfWarrantsAndConversionOption
0 usd
jksm Derivative Liability Recognized At Issuance Of Warrants And Conversion Option
DerivativeLiabilityRecognizedAtIssuanceOfWarrantsAndConversionOption
493670 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
72958 usd
us-gaap Restricted Stock Expense
RestrictedStockExpense
2670 usd
us-gaap Restricted Stock Expense
RestrictedStockExpense
72000 usd
jksm Common Stock Issued To Settle Share Payable
CommonStockIssuedToSettleSharePayable
331600 shares
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements is in conformity with U.S. GAAP and requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Such estimates and assumptions impact both assets and liabilities, including but not limited to net realizable value of accounts receivable and inventory, estimated useful lives and potential impairment of property and equipment, estimate of fair value of share based payments and derivative liabilities, estimates of fair value of warrants issued and recorded as debt discount and estimates of the probability and potential magnitude of contingent liabilities. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future nonconforming events. Accordingly, actual results could differ significantly from estimates.</p>
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
74000 usd
jksm Inventory Allowance
InventoryAllowance
18800 usd
CY2022Q3 us-gaap Deferred Revenue
DeferredRevenue
147772 usd
CY2022Q3 jksm Machine Sales
MachineSales
225335 usd
CY2021Q3 jksm Machine Sales
MachineSales
1280139 usd
jksm Machine Sales
MachineSales
2416419 usd
jksm Machine Sales
MachineSales
4465754 usd
CY2022Q3 jksm Non Machine Sales
NonMachineSales
267556 usd
CY2021Q3 jksm Non Machine Sales
NonMachineSales
699253 usd
jksm Non Machine Sales
NonMachineSales
1320856 usd
jksm Non Machine Sales
NonMachineSales
914861 usd
CY2022Q3 us-gaap Revenues
Revenues
492891 usd
CY2021Q3 us-gaap Revenues
Revenues
1949392 usd
us-gaap Revenues
Revenues
3737275 usd
us-gaap Revenues
Revenues
5380615 usd
jksm Summary Of Effect Of Potential Dilutive Issuances
SummaryOfEffectOfPotentialDilutiveIssuances
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Nine Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> </strong><strong>September 30, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net income (loss) attributable to common stockholders</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(341,763 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(115,430 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(393,202 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">179,828</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Preferred stock dividends</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,315</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Derivative gain</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,171,242 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Interest expense associated with convertible debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">715,401</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net income (loss) for dilutive calculation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(341,763 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(115,430 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(393,202 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(271,698 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Weighted average shares outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">80,855,219</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">73,645,455</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">78,700,014</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">71,490,810</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dilutive effect of preferred stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,400,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dilutive effect of convertible debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,969,136</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dilutive effect of common stock warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Weighted average shares outstanding for diluted net income (loss) per share</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">80,855,219</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">73,645,455</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">78,700,014</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">76,859,946</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-341763 usd
CY2021Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-115430 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-393202 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
179828 usd
CY2022Q3 jksm Dividends Preferred Stock1
DividendsPreferredStock1
0 usd
CY2021Q3 jksm Dividends Preferred Stock1
DividendsPreferredStock1
0 usd
jksm Dividends Preferred Stock1
DividendsPreferredStock1
0 usd
jksm Dividends Preferred Stock1
DividendsPreferredStock1
4315 usd
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 usd
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1171242 usd
CY2022Q3 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 usd
CY2021Q3 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 usd
jksm Net Income Loss For Dilutive Calculation
NetIncomeLossForDilutiveCalculation
-393202 usd
jksm Net Income Loss For Dilutive Calculation
NetIncomeLossForDilutiveCalculation
-271698 usd
CY2022Q3 jksm Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
80855219 usd
CY2021Q3 jksm Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
73645455 usd
jksm Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
78700014 usd
jksm Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
71490810 usd
CY2022Q3 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
CY2021Q3 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
1400000 usd
CY2022Q3 jksm Dilutive Effect Of Convertible Debt
DilutiveEffectOfConvertibleDebt
0 usd
CY2021Q3 jksm Dilutive Effect Of Convertible Debt
DilutiveEffectOfConvertibleDebt
0 usd
jksm Dilutive Effect Of Convertible Debt
DilutiveEffectOfConvertibleDebt
0 usd
jksm Dilutive Effect Of Convertible Debt
DilutiveEffectOfConvertibleDebt
3969136 usd
CY2022Q3 jksm Dilutive Effect Of Common Stock Warrants
DilutiveEffectOfCommonStockWarrants
0 usd
CY2021Q3 jksm Dilutive Effect Of Common Stock Warrants
DilutiveEffectOfCommonStockWarrants
0 usd
jksm Dilutive Effect Of Common Stock Warrants
DilutiveEffectOfCommonStockWarrants
0 usd
CY2022Q3 jksm Weighted Average Shares Outstanding For Diluted Net Income Loss Per Share
WeightedAverageSharesOutstandingForDilutedNetIncomeLossPerShare
80855219 usd
CY2021Q3 jksm Weighted Average Shares Outstanding For Diluted Net Income Loss Per Share
WeightedAverageSharesOutstandingForDilutedNetIncomeLossPerShare
73645455 usd
jksm Weighted Average Shares Outstanding For Diluted Net Income Loss Per Share
WeightedAverageSharesOutstandingForDilutedNetIncomeLossPerShare
78700014 usd
jksm Weighted Average Shares Outstanding For Diluted Net Income Loss Per Share
WeightedAverageSharesOutstandingForDilutedNetIncomeLossPerShare
76859946 usd
CY2022Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
14279965 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2469136 shares
CY2022Q3 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
18066667 shares
us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
2777778 shares
CY2021Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
11189056 shares
us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
3969136 shares
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20644 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20644 usd
CY2022Q3 jksm Less Accumulated Depreciation
LessAccumulatedDepreciation
-20031 usd
CY2021Q4 jksm Less Accumulated Depreciation
LessAccumulatedDepreciation
-19172 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
613 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1472 usd
us-gaap Depreciation
Depreciation
859 usd
us-gaap Depreciation
Depreciation
1512 usd
CY2021Q3 jksm Convertible Notes Payable1
ConvertibleNotesPayable1
444444 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
1070069 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
641690 usd
CY2021Q4 jksm Common Stock Designated
CommonStockDesignated
200000000 shares
CY2021Q4 jksm Preferred Stock Designated
PreferredStockDesignated
30000000 shares
CY2021Q4 us-gaap Share Price
SharePrice
0.18
CY2022Q3 us-gaap Notes Payable
NotesPayable
833307 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
914121 usd
CY2022Q3 jksm Debt Instrument Unamortized Discount1
DebtInstrumentUnamortizedDiscount1
100955 usd
CY2021Q4 jksm Debt Instrument Unamortized Discount1
DebtInstrumentUnamortizedDiscount1
121309 usd
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
112324 usd
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
87774 usd
CY2022Q3 jksm Notes Payable Net Of Current Portion
NotesPayableNetOfCurrentPortion
620028 usd
CY2021Q4 jksm Notes Payable Net Of Current Portion
NotesPayableNetOfCurrentPortion
705038 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
20355 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
16 usd
CY2022Q3 jksm Less Debt Discount And Deferred Finance Costs On Short Term Convertible Notes
LessDebtDiscountAndDeferredFinanceCostsOnShortTermConvertibleNotes
0 usd
CY2022Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2022Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
444444 usd
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
744444 usd
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2021Q4 jksm Less Debt Discount And Deferred Finance Costs On Short Term Convertible Notes
LessDebtDiscountAndDeferredFinanceCostsOnShortTermConvertibleNotes
-43269 usd
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
444444 usd
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
701175 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
136289 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
4338 usd
jksm Convertible Notes Payable1
ConvertibleNotesPayable1
435730 usd
jksm Convertible Notes Payable1
ConvertibleNotesPayable1
1171242 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.18
CY2021Q4 jksm Stock Exercise Price
StockExercisePrice
0.27
jksm Shares Remaining To Be Issued
SharesRemainingToBeIssued
2222221 shares
CY2021 jksm Shares Remaining To Be Issued
SharesRemainingToBeIssued
2222221 shares
CY2022Q3 jksm Subscriptions Payable Liability Balance
SubscriptionsPayableLiabilityBalance
499999 usd
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1389175 shares
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
68977 usd
CY2022Q3 jksm Common Stock Share Issued
CommonStockShareIssued
2670034 shares
jksm Fair Value Of Common Stock
FairValueOfCommonStock
139800 usd
jksm Aggregate Number Beginning
AggregateNumberBeginning
11189056 shares
jksm Aggregate Exercise Price Beginning
AggregateExercisePriceBeginning
2646044 usd
jksm Weighted Average Exercise Price Beginning
WeightedAverageExercisePriceBeginning
0.24
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4000000 shares
jksm Aggregate Exercise Price Granted
AggregateExercisePriceGranted
800000 usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.20
jksm Aggregate Exercise Price Exercised1
AggregateExercisePriceExercised1
0 usd
jksm Aggregate Exercise Price Exercised
AggregateExercisePriceExercised
0 usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
jksm Less Forfeited And Cancelled
LessForfeitedAndCancelled
-909091 usd
jksm Aggregate Exercise Price Forfeited And Cancelled
AggregateExercisePriceForfeitedAndCancelled
-500000 usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.55
jksm Aggregate Number Ending
AggregateNumberEnding
14279965 shares
jksm Aggregate Exercise Price Ending
AggregateExercisePriceEnding
2946044 usd
jksm Weighted Average Exercise Price Ending
WeightedAverageExercisePriceEnding
0.21
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P2Y3M3D
jksm Description For Extention Of Lease Term
DescriptionForExtentionOfLeaseTerm
beginning February 15, 2022 through February 28, 2025
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3267 usd
jksm Lease Payments Increased Percentage
LeasePaymentsIncreasedPercentage
0.04 pure
CY2022Q3 jksm Right Of Use Asset And Lease Liability
RightOfUseAssetAndLeaseLiability
105822 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
26811 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
0 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
24220 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
82668 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
us-gaap Sublease Income
SubleaseIncome
0 usd
us-gaap Sublease Income
SubleaseIncome
0 usd
us-gaap Lease Cost
LeaseCost
51031 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
85597 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
32785 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
55121 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
87906 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
0 usd
CY2022Q3 jksm Incremental Borrowing Rate Percentage
IncrementalBorrowingRatePercentage
0.10 pure
jksm Lease Remaining Terms
LeaseRemainingTerms
P2Y5M1D
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
9801 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
40511 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
42123 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
7065 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
99500 usd
CY2022Q3 jksm Less Interest Lessee Operating Lease Liability
LessInterestLesseeOperatingLeaseLiability
11594 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
87906 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1696374 usd
jksm Description Of Management Intention Of Not Removing Accrued Liabilities
DescriptionOfManagementIntentionOfNotRemovingAccruedLiabilities
Management does not intend to remove these liabilities of $1,696,374 from the Company’s financial statements until such time that the liability is formally settled or judicially released in accordance with ASC 405-20-40. Due to the lack of written agreements and other factors noted above, management concluded to no longer accrue interest on these loans.

Files In Submission

Name View Source Status
0001477932-22-008582-index-headers.html Edgar Link pending
0001477932-22-008582-index.html Edgar Link pending
0001477932-22-008582.txt Edgar Link pending
0001477932-22-008582-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
jksm-20220930.xsd Edgar Link pending
jksm_10q.htm Edgar Link pending
jksm_ex311.htm Edgar Link pending
jksm_ex312.htm Edgar Link pending
jksm_ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
jksm-20220930_lab.xml Edgar Link unprocessable
jksm-20220930_def.xml Edgar Link unprocessable
jksm-20220930_cal.xml Edgar Link unprocessable
jksm_10q_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
jksm-20220930_pre.xml Edgar Link unprocessable